Primary Site >> Colorectal Cancer

Gene >> EIF4EBP1

Journal: J Biol Chem. 2002 Aug 2;277(31):28127-34. Epub 2002 May 8.
Title: Predominant nuclear localization of mammalian target of rapamycin in normal and malignant cells in culture.
Author: Zhang, Xiongwen|Shu, Lili|Hosoi, Hajime|Murti, K Gopal|Houghton, Peter J
PMID: 12000755
Journal: Anticancer Drugs. 2005 Jun;16(5):533-41.
Title: The patellazoles inhibit protein synthesis at nanomolar concentrations in human colon tumor cells.
Author: Richardson, Adam D|Aalbersberg, William|Ireland, Chris M
PMID: 15846119
Journal: Carcinogenesis. 2006 Jul;27(7):1323-33. Epub 2006 Mar 10.
Title: Global alterations in mRNA polysomal recruitment in a cell model of colorectal cancer progression to metastasis.
Author: Provenzani, Alessandro|Fronza, Raffaele|Loreni, Fabrizio|Pascale, Alessia|Amadio, Marialaura|Quattrone, Alessandro
PMID: 16531451
Journal: Cancer Res. 2007 Apr 15;67(8):3569-73.
Title: Phenethyl isothiocyanate, a cancer chemopreventive constituent of cruciferous vegetables, inhibits cap-dependent translation by regulating the level and phosphorylation of 4E-BP1.
Author: Hu, Jing|Straub, Jonathan|Xiao, Dong|Singh, Shivendra V|Yang, Hsin-Sheng|Sonenberg, Nahum|Vatsyayan, Jaya
PMID: 17440067
Journal: J Clin Oncol. 2008 Apr 1;26(10):1603-10.
Title: Dose- and schedule-dependent inhibition of the mammalian target of rapamycin pathway with everolimus: a phase I tumor pharmacodynamic study in patients with advanced solid tumors.
Author: Tabernero, Josep|Rojo, Federico|Calvo, Emiliano|Burris, Howard|Judson, Ian|Hazell, Katharine|Martinelli, Erika|Ramon y Cajal, Santiago|Jones, Suzanne|Vidal, Laura|Shand, Nicholas|Macarulla, Teresa|Ramos, Francisco Javier|Dimitrijevic, Sasa|Zoellner, Ulrik
PMID: 18332469
Journal: Ann Surg Oncol. 2009 Sep;16(9):2617-28.
Title: mTOR signaling pathway is a target for the treatment of colorectal cancer.
Author: Zhang, Yan-Jie|Dai, Qiang|Sun, Dan-Feng|Xiong, Hua|Tian, Xiao-Qing|Gao, Feng-Hou|Xu, Mang-Hua|Chen, Guo-Qiang|Han, Ze-Guang|Fang, Jing-Yuan
PMID: 19517193
Journal: Mol Cancer Ther. 2010 Dec;9(12):3158-63.
Title: Modulation of 4E-BP1 function as a critical determinant of enzastaurin-induced apoptosis.
Author: Dumstorf, Chad A|Konicek, Bruce W|McNulty, Ann M|Parsons, Stephen H|Furic, Luc|Sonenberg, Nahum|Graff, Jeremy R
PMID: 20971826
Journal: Ann Surg Oncol. 2011 Feb;18(2):580-8.
Title: mTOR signaling is involved in indomethacin and nimesulide suppression of colorectal cancer cell growth via a COX-2 independent pathway.
Author: Zhang, Yan-Jie|Bao, Yu-Jie|Dai, Qiang|Yang, Wen-Yan|Cheng, Peng|Zhu, Li-Ming|Wang, Bi-Jun|Jiang, Fo-Hu
PMID: 20803081
Journal: Eur J Cancer. 2012 Feb;48(3):396-406.
Title: The phosphoinositide 3-kinase/mammalian target of rapamycin inhibitor NVP-BEZ235 is effective in inhibiting regrowth of tumour cells after cytotoxic therapy.
Author: Hernlund, Emma|Olofsson, Maria Hagg|Fayad, Walid|Fryknas, Marten|Lesiak-Mieczkowska, Karolina|Zhang, Xiaonan|Brnjic, Slavica|Schmidt, Vivien|D'Arcy, Padraig|Sjoblom, Tobias|De Milito, Angelo|Larsson, Rolf|Linder, Stig
PMID: 22154651
Journal: Cell Cycle. 2012 Feb 1;11(3):594-603.
Title: mTOR-independent 4E-BP1 phosphorylation is associated with cancer resistance to mTOR kinase inhibitors.
Author: Zhang, Yanjie|Zheng, X F Steven
PMID: 22262166
Journal: Br J Cancer. 2012 Apr 10;106(8):1386-94.
Title: The synergistic interaction of MEK and PI3K inhibitors is modulated by mTOR inhibition.
Author: Haagensen, E J|Kyle, S|Beale, G S|Maxwell, R J|Newell, D R
PMID: 22415236
Journal: Int J Oncol. 2013 Jun;42(6):2134-40.
Title: Altered cardiac muscle mTOR regulation during the progression of cancer cachexia in the ApcMin/+ mouse.
Author: Manne, Nandini D P K|Lima, M|Enos, R T|Wehner, P|Carson, J A|Blough, Eric
PMID: 23589074
Journal: PLoS One. 2013 Dec 10;8(12):e81763.
Title: The enhanced in vivo activity of the combination of a MEK and a PI3K inhibitor correlates with [18F]-FLT PET in human colorectal cancer xenograft tumour-bearing mice.
Author: Haagensen, Emma J|Thomas, Huw D|Wilson, Ian|Harnor, Suzannah J|Payne, Sara L|Rennison, Tommy|Smith, Kate M|Maxwell, Ross J|Newell, David R
PMID: 24339963
Journal: Eur J Cancer. 2013 Oct;49(15):3311-9.
Title: Aldose reductase inhibition suppresses colon cancer cell viability by modulating microRNA-21 mediated programmed cell death 4 (PDCD4) expression.
Author: Saxena, Ashish|Shoeb, Mohammad|Ramana, Kota V|Srivastava, Satish K
PMID: 23827854
Journal: Tumour Biol. 2013 Apr;34(2):683-93.
Title: Upregulation of the antiapoptotic factor Livin contributes to cisplatin resistance in colon cancer cells.
Author: Ding, Zhen-Yu|Liu, Gui-Hong|Olsson, Birgit|Sun, Xiao-Feng
PMID: 23188704
Journal: BMC Cancer. 2014 Mar 6;14:160.
Title: Expression of phosphoenolpyruvate carboxykinase linked to chemoradiation susceptibility of human colon cancer cells.
Author: Park, Ji-Won|Kim, Seung Cheol|Kim, Won Ki|Hong, Jun Pyu|Kim, Kyung-Hee|Yeo, Hyun Yang|Lee, Jae Yong|Kim, M Sun|Kim, Jong Heon|Yang, Se Young|Kim, Dae Yong|Oh, Jae Hwan|Cho, Jae Youl|Yoo, Byong Chul
PMID: 24602180
Journal: PLoS One. 2014 Mar 25;9(3):e92966.
Title: Depletion of white adipose tissue in cancer cachexia syndrome is associated with inflammatory signaling and disrupted circadian regulation.
Author: Tsoli, Maria|Schweiger, Martina|Vanniasinghe, Anne S|Painter, Arran|Zechner, Rudolf|Clarke, Stephen|Robertson, Graham
PMID: 24667661
Journal: Cancer Cell Microenviron. 2014;1(5).
Title: New insights into 4E-BP1-regulated translation in cancer progression and metastasis.
Author: Wang, Jun|Ye, Qing|She, Qing-Bai
PMID: 26005705
Journal: Nature. 2015 Jan 22;517(7535):497-500.
Title: mTORC1-mediated translational elongation limits intestinal tumour initiation and growth.
Author: Faller, William J|Jackson, Thomas J|Knight, John Rp|Ridgway, Rachel A|Jamieson, Thomas|Karim, Saadia A|Jones, Carolyn|Radulescu, Sorina|Huels, David J|Myant, Kevin B|Dudek, Kate M|Casey, Helen A|Scopelliti, Alessandro|Cordero, Julia B|Vidal, Marcos|Pende,
PMID: 25383520
Journal: Oncogene. 2016 Jun 9;35(23):3004-15.
Title: PAT4 levels control amino-acid sensitivity of rapamycin-resistant mTORC1 from the Golgi and affect clinical outcome in colorectal cancer.
Author: Fan, S-J|Snell, C|Turley, H|Li, J-L|McCormick, R|Perera, S M W|Heublein, S|Kazi, S|Azad, A|Wilson, C|Harris, A L|Goberdhan, D C I
PMID: 26434594
Journal: Sci Signal. 2016 Oct 11;9(449):rs11.
Title: Impaired coordination between signaling pathways is revealed in human colorectal cancer using single-cell mass cytometry of archival tissue blocks.
Author: Simmons, Alan J|Scurrah, Cherie R|McKinley, Eliot T|Herring, Charles A|Irish, Jonathan M|Washington, M Kay|Coffey, Robert J|Lau, Ken S
PMID: 27729552
Journal: J Cell Biol. 2017 Jun 5;216(6):1567-1577.
Title: Oncogenic beta-catenin and PIK3CA instruct network states and cancer phenotypes in intestinal organoids.
Author: Riemer, Pamela|Rydenfelt, Mattias|Marks, Matthias|van Eunen, Karen|Thedieck, Kathrin|Herrmann, Bernhard G|Bluthgen, Nils|Sers, Christine|Morkel, Markus
PMID: 28442534
Journal: Neoplasma. 2017;64(5):787-794.
Title: Phosphorylated 4E-BP1 is associated with tumor progression and adverse prognosis in colorectal cancer.
Author: Chen, Y|Wang, J|Fan, H|Xie, J|Xu, L|Zhou, B
PMID: 28592131
Journal: J Gastrointest Cancer. 2017 Nov 7. pii: 10.1007/s12029-017-0024-9.
Title: A Deregulated PI3K-AKT Signaling Pathway in Patients with Colorectal Cancer.
Author: Zhang, Tao|Ma, Yuanping|Fang, Jiansong|Liu, Chang|Chen, Liangrong
PMID: 29110225
Journal: Mol Cancer Res. 2018 Sep 10. pii: 1541-7786.MCR-18-0650.
Title: Repurposing of mTOR Complex inhibitors Attenuates MCL-1 and sensitizes to PARP inhibition.
Author: Mattoo, Abid R|Joun, Alex|Jessup, J Milburn
PMID: 30201826